ORIGINAL PAPERS

Interleukin 1 Trials in Cancer Patients: A Review of the Toxicity, Antitumor and Hematopoietic Effects

Salvatore Veltri, John W. Smith, II
The Oncologist 1996; 1: 190-200
[Abstract] [Full Text] [PDF]  

Diagnosis and Treatment of Early-Stage Non-Small Cell Lung Cancer

Jemi Olak, Arthur Ng
The Oncologist 1996; 1: 201-209
[Abstract] [Full Text] [PDF]  

Beware the Medical-Industrial Complex

Craig W. Stevens, Eli Glatstein
The Oncologist 1996; 1: 190
[Full Text] [PDF]  

Multimodality Therapy for Esophageal Cancer

J.R. Siewert, H.J. Stein, U. Fink
The Oncologist 1996; 1: 210-218
[Abstract] [Full Text] [PDF]  

Message from the Executive Editor

Martin J. Murphy, Jr.
The Oncologist 1996; 1: 219-220
[Full Text] [PDF]  

A Tribute to Bruce Chabner

Dwight Kaufman
The Oncologist 1996; 1: 221-222
[Full Text] [PDF]  

Resistance Mechanisms to Methotrexate in Tumors

J.R. Bertino, E. Göker, R. Gorlick, W.W. Li, D. Banerjee
The Oncologist 1996; 1: 223-226
[Abstract] [Full Text] [PDF]  

Modulating the Radiation Response

C. Norman Coleman
The Oncologist 1996; 1: 227-231
[Abstract] [Full Text] [PDF]  

From Plasma Kinetics to Cellular Pharmacology

H.M. Pinedo
The Oncologist 1996; 1: 232-233
[Abstract] [Full Text] [PDF]  

The Importance of Drug Scheduling in Cancer Chemotherapy: Etoposide as an Example

Kenneth R. Hande
The Oncologist 1996; 1: 234-239
[Abstract] [Full Text] [PDF]  

The Clinical Development of Paclitaxel: A Successful Collaboration of Academia, Industry and the National Cancer Institute

Ross C. Donehower
The Oncologist 1996; 1: 240-243
[Abstract] [Full Text] [PDF]  

Methotrexate: An Effective Agent for Treating Cancer and Building Careers. The Polyglutamate Era

Richard L. Schilsky
The Oncologist 1996; 1: 244-247
[Abstract] [Full Text] [PDF]  

Biochemical and Molecular Studies of Human Methenyltetrahydrofolate Synthetase

Jacques Jolivet, Alain Dayan, Myriam Beauchemin, Dounia Chahla, Aline Mamo, Richard Bertrand
The Oncologist 1996; 1: 248-253
[Abstract] [Full Text] [PDF]  

New Concepts for the Development and Use of Antifolates

Edward Chu, Jean L. Grem, Patrick G. Johnston, Carmen J. Allegra
The Oncologist 1996; 1: 255-259
[Abstract] [Full Text] [PDF]  

P-Glycoprotein, Multidrug Resistance and Protein Kinase C

Robert L. Fine, Timothy C. Chambers, Clifford W. Sachs
The Oncologist 1996; 1: 261-268
[Abstract] [Full Text] [PDF]  

Clinical Reversal of Multidrug Resistance

Susan E. Bates, Wyndham H. Wilson, Antonio T. Fojo, Manuel Alvarez, Zhirong Zhan, Joanna Regis, Rob Robey, Curtis Hose, Anne Monks, Yoon Koo Kang, Bruce Chabner
The Oncologist 1996; 1: 269-275
[Abstract] [Full Text] [PDF]  

Closing Remarks

Eddie Reed
The Oncologist 1996; 1: 276-277
[Full Text] [PDF]  

REGARDING: VALERO V, BUZDAR AU, HORTOBAGYI GN. "LOCALLY ADVANCED BREAST CANCER," THE ONCOLOGIST 1996;1:8-17.

Professor R.T.D. Oliver, Vicente Valero, Aman U. Buzdar, Gabriel N. Hortobagyi
The Oncologist 1996; 1: 278-279
[Full Text] [PDF]  

News Bulletin

The Oncologist 1996; 1: 280-283
[Full Text] [PDF]  

Physician Education

Yataro Yoshida
The Oncologist 1996; 1: 284-287
[Full Text] [PDF]  

To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.